Edurant Ped Alternatives Compared
Edurant Ped | Biktarvy | Cabenuva |
|
---|
Edurant Ped (rilpivirine) | Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | Cabenuva (cabotegravir / rilpivirine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for HIV Infection. Edurant Ped may also be used for purposes not listed in this medication guide. |
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Prescription only
Prescribed for HIV Infection. Cabenuva may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Edurant Ped (rilpivirine) | More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | More about Cabenuva (cabotegravir / rilpivirine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Biktarvy has an average rating of 7.2 out of 10 from a total of 208 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 20% reported a negative effect. |
Cabenuva has an average rating of 8.0 out of 10 from a total of 19 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Edurant Ped side effects in more detail. |
See also: Biktarvy side effects in more detail. |
See also: Cabenuva side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Biktarvy prices |
View all Cabenuva prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other rilpivirine brands include: Edurant |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
50 hours |
180 hours |
50 hours (empirically) |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 401 drugs are known to interact with Edurant Ped:
|
A total of 427 drugs are known to interact with Biktarvy:
|
A total of 443 drugs are known to interact with Cabenuva:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
February 07, 2018 |
January 21, 2021 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.